Metabolic Diseases are diseases caused by excessive or lack of accumulation of certain metabolic substances such as sugar, fat, protein, strontium, calcium and copper, such as diabetes, due to congenital genetic defects or visceral pathological changes and dysfunction. Gout, scurvy, osteoporosis, etc. The main research directions include metabolic disease biomarkers, pathogenic mechanisms, drug development, gene therapy, and clinical trials.

RiboBio provides comprehensive solutions for the research and screening of pathogenic genes related to metabolic diseases, including high-throughput screening/high-content analysis and screening, genome-wide siRNA libraries, and high-throughput sequencing.